Brink's receives CMA acceptance in principle for remedy tied to pending NCR Atleos acquisition
BCO•Brink's said the CMA accepted in principle its proposed remedy related to the pending NCR Atleos acquisition, which remains on track to close early in Q1 2027.
1. Remedy accepted in principle
Brink's said the CMA accepted in principle its proposed remedy related to the company's pending acquisition of NCR Atleos. Brink's said the acquisition remains on track to close early in Q1 2027.
